ECLIPSE (Enzyme Coupler Induced Pathway Silencing) is a novel strategy developed for anti-cancer drug design. An ECLIPSE-designed entity is a bifunctional molecule consisting of​ a target protein ligand and a functional enzyme ligand, which are connected by a linker or directly fused.